FOXO4-DRI × glowaminos peptides — lab test, June 2026
COA ACC-2026-3664 matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
BYTZWGRATest results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10.63 mg
106% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.7 mg using the measured mass, against 2.5 mg on the label — 6% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | ACC-2026-3664 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 10 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of FOXO4-DRI from glowaminos peptides, performed by ILS Laboratories on June 10, 2026. Reported purity: 99.86%. Net content: 10.63 mg against 10 mg labeled (106% of label). Batch GL-010147. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of FOXO4-DRI from glowaminos peptides
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| GL-010029 | 12 Feb 2026 | freedomdiagnosticstesting.com | 99.891% | 124% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion